We then examined mutation and copy number alterations (CNAs) in the liver cancer TCGA dataset through the cBioPortal web and found that approximately 3% of the samples showed mutation, amplification, deep deletion, or mRNA upregulation of GPR50 genes (Figure 1E). This evidence concerns the gene GPR50 and liver cancer.